Selected Publications
Drennan CN, Pauley JL, Christensen AM, Jacobs TW, Bragg AW, Porter JS, Bourque MS. Pharmacist Effect on Discharge Follow-Up Education in Pediatric Oncology Outpatient Clinics: A Quality Improvement Study. J Pediatr Pharmacol Ther. 2023;28(3):262-267.
Bagchi A, Orr BA, Campagne O, Dhanda S, Nair S, Tran Q, Christensen AM, Gajjar A, Furtado LV, Vasilyeva A, Boop F, Stewart C, Robinson GW. Lorlatinib in a Child with ALK-Fusion-Positive High-Grade Glioma. N Engl J Med. 2021 Aug 19;385(8):761-763.
Khan RB, Bano M, Wang F, Haitao P, Christensen A, Smith J, Simmons A, Sadighi ZS. Height, weight, and cardiovascular effects of stimulants on children with brain tumors. Pediatr Blood Cancer. 2021;68(1):e28740.
Chow JW, Chicella MF, Christensen AM, Moneymaker CS, Harrington J, Dice JE. Improving Palivizumab Compliance rough a Pharmacist-Managed RSV Prevention Clinic. J Pediatr Pharmacol Ther. 2017 Sep-Oct;22(5):338-343.
Vivek Subbiah, Jitesh D Kawedia, Anthony Christensen, Kenneth R. Hess, Kayuri Patel, Elaine Wood, Ryan D Bitar, Najat C. Daw. Comparison of adult oncology phase 1 trials to pediatric oncology phase 1 trials of targeted therapies. J Clin Oncol 2015 33:15_suppl, 2581-2581
Maher OM, Christensen AM, Yedururi S, Bell D, Tarek N. Histone deacetylase inhibitor for NUT midline carcinoma. Pediatr Blood Cancer. 2015;62(4):715-717.
Christensen AM, Pauley JL, Molinelli AR, Panetta JC, Ward DA, Stewart CF, Hoffman JM, Howard SC, Pui CH, Pappo AS, Relling MV, Crews KR. Resumption of high-dose methotrexate after acute kidney injury and glucarpidase use in pediatric oncology patients. Cancer. 2012;118(17):4321-4330.
Ceja ME, Christensen AM, Yang SP. Dosing Considerations in Pediatric Oncology. US Pharm. 2013;(38)(Oncology suppl):8-11.
Last update: September 2023